Day: January 13, 2025

Reports $709 million in preliminary1 full-year 2024 U.S. net product revenues$611 million in SYFOVRE® U.S. net product revenues, including $167 million in 4Q 2024 $98 million in EMPAVELI® U.S. net product revenues, including $23 million in 4Q 2024Expects submission of EMPAVELI sNDA for C3G and primary IC-MPGN in early 2025; U.S. launch anticipated in 2H 2025, if approved Plans initiation of Phase 3 studies of pegcetacoplan in two additional nephrology indications in 2H 2025 Adam Townsend, chief operating officer, to depart Apellis in February; David Acheson named executive vice president of commercial Maintained strong financial position with year-end cash of approximately $410 million; projected revenues and cash expected to be sufficient to fund operations to profitabilityWALTHAM, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) —...

Robust plan benefits powered member growth, mainly driven by switchers from other plans Company will focus on balancing profitability with strategic investments in growth and technology to take advantage of strong market opportunity ~95% of Clover’s January 1, 2025 membership is in its flagship 4 Star PPO planWILMINGTON, Del., Jan. 13, 2025 (GLOBE NEWSWIRE) — Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced a 27% year-over-year growth of its Medicare Advantage (MA) membership during the most recent Annual Election Period (AEP). The Company enters 2025 with over 100,000 members, approximately 95% of whom are enrolled in Clover’s flagship 4-Star PPO plan. “Driven by robust plan benefits and our 4 Star rating, we’ve delivered exceptional member growth, and I feel honored...

Fourth Quarter 2024 worldwide revenue of ~$48.8 to $49.0 million representing growth of ~26%Achieved adjusted EBITDA profitability in the fourth quarter SANTA CLARA, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) — SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced its preliminary and unaudited revenue and cash and cash equivalents for fourth quarter and full year 2024. Fourth Quarter 2024 Summary (any comparisons are to the prior year period)Worldwide revenue between $48.8 – $49.0 million, representing ~26% growth U.S. revenue between $46.7 – $46.9 million, representing ~28% growth Ended the quarter with ~1,390 active physicians in the U.S., representing ~23% growth Cash and marketable securities of ~$150 million, implying net cash use of ~$0.8 million in the...

Entering 2025 having demonstrated rapid translation of genetic insights to positive clinical data; advancing clinically validated and multi-modal pipeline with the potential to treat well over 100 million patients CTAs submitted for Phase 1 INLIGHT clinical trial of WVE-007, a novel, long-acting, muscle-sparing GalNAc-siRNA approach for obesity targeting INHBE grounded in human genetics; proof-of-concept clinical data expected in 2025 Pioneering entirely new therapeutic field of RNA editing and building on positive WVE-006 proof-of mechanism clinical data; expect multidose AATD data, new preclinical data from hepatic and extra-hepatic RNA editing programs and candidate selections in 2025 Expect feedback from regulators and 48-week FORWARD-53 data for WVE-N531 in DMD in 1Q 2025; positive interim data demonstrated highly consistent dystrophin...

IQVIA, Illumina, Mayo Clinic and Arc Institute Harness NVIDIA AI and Accelerated Computing to Transform $10 Trillion Healthcare and Life Sciences IndustryNVIDIA Partners With Industry Leaders to Advance Genomics, Drug Discovery and HealthcareHealthcare leaders IQVIA, Illumina and Mayo Clinic, as well as Arc Institute, are using the latest NVIDIA technologies to develop solutions that will help advance human health.SAN FRANCISCO, Jan. 13, 2025 (GLOBE NEWSWIRE) — J.P. Morgan Healthcare Conference — NVIDIA today announced new partnerships to transform the $10 trillion healthcare and life sciences industry by accelerating drug discovery, enhancing genomic research and pioneering advanced healthcare services with agentic and generative AI. The convergence of AI, accelerated computing and biological data is turning healthcare...

More patients treated with ZTlido® saw either a decrease or discontinuation of opioid use compared with those treated with the 5% patch (51.9% vs. 45.5%). Of all study patients reporting a decrease in opioid use, significantly more in the ZTlido® group experienced a 20% or greater reduction in opioid use, compared with those treated with 5% lidocaine patch (21.3% vs. 13.4%; P=0.0008). Patients on ZTlido® had a non-significant change in their baseline opioid use (+3.1%; P=0.146), while those using the 5% patch experienced a significant increase in opioid use from baseline (+42.9%; P

2025 Root Insurance NADA Bourbon Street Experience2025 Root Insurance NADA Bourbon Street Experience InviteCOLUMBUS, Ohio, Jan. 13, 2025 (GLOBE NEWSWIRE) — Root, Inc. (NASDAQ: ROOT), a leading technology company powering insurance solutions and the parent company of Root Insurance Company, is excited to announce its presence at the National Automobile Dealers Association (NADA) Show in New Orleans, Louisiana, from January 23 to January 26, 2025. As the largest auto insurtech in the country, Root is revolutionizing the car insurance industry by using data-driven insights and mobile technology to offer fair and personalized pricing based primarily on driving behavior. At the NADA Show, Root will engage with automotive leaders, dealers, and partners to showcase its advanced solutions that create seamless and efficient insurance...

California-Born Pizza Brand to Serve Up Free Personal Cheese Pizzas at Los Angeles Area Locations  LOS ANGELES, Jan. 13, 2025 (GLOBE NEWSWIRE) — Round Table Pizza, a California-born pizza brand owned by FAT Brands Inc., is showing its support for first responders fighting the devastating Los Angeles wildfires. Now through Thursday, Jan. 16, first responders can visit any of the chain’s 50 plus Los Angeles area restaurants and receive a free Personal Cheese Pizza. “We are incredibly grateful to the first responders who have been working day and night to fight the fires,” said Taylor Voelker, Senior Director of Marketing for Round Table Pizza. “We look forward to welcoming first responders to our stores and personally thanking them for their efforts and dedication to Los Angeles – a city that means so much to the Round Table Pizza...

Hong Kong, Jan. 13, 2025 (GLOBE NEWSWIRE) — Ming Shing Group Holdings Limited (the “Company” or “Ming Shing”) (NASDAQ: MSW), a Hong Kong-based company mainly engaged in wet trades works whose mission it is to become the leading wet trades works service provider in Hong Kong, announces a significant update in its business development. Ming Shing is pleased to announce that its wholly-owned Hong Kong subsidiary, Lead Benefit (HK) Limited (“Lead Benefit”), purchased 500 Bitcoins at an average price of US$94,375 per Bitcoin on January 9, 2025, with a total investment of approximately US$47 million. Lead Benefit was incorporated on December 23, 2024, with Lead Benefit International Limited, as its sole shareholder. Lead Benefit International Limited, a BVI business company, was incorporated on December 9, 2024, with Ming Shing as its...